🇺🇸 FDA

Company profile · Sponsor

FENNEC

FENNEC PHARMACEUTICALS INC.

FENC · NYSE biotech RESEARCH TRIANGLE PARK, NC, USA
Pipeline
1
Drugs
1
Patents
8

Quick answer

FENNEC (FENC) is a biotech company. headquartered in RESEARCH TRIANGLE PARK, NC, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 1 drug, and 8 patents to this profile..

Company facts

Ticker FENC
Exchange NYSE
Company type biotech
Headquarters RESEARCH TRIANGLE PARK, NC, USA
SEC CIK 0001211583

Pipeline (1)

Search pipeline →

  1. Pedmark® STS

    FENNEC

    Solid Tumor Malignancies

    phase 2 small molecule active

    1 trial

Drugs (1)

Search drugs →

  1. sodium thiosulfate

    PEDMARQSI

    INJECTION approved

Patents (8)

Search patents →

  1. US 12311026

    Therapeutic uses for sodium thiosulfate formulations

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11998604

    Therapeutic uses for sodium thiosulfate formulations

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11992530

    Therapeutic uses for sodium thiosulfate and formulations

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11964018

    Therapeutic uses for sodium thiosulfate formulations

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11617793

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11510984

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11291728

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10792363

    Anhydrous sodium thiosulfate and formulations thereof

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is FENNEC?

FENNEC (FENC) is a biotech company. headquartered in RESEARCH TRIANGLE PARK, NC, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 1 drug, and 8 patents to this profile..

What pipeline programs does FENNEC sponsor?

We track 1 ClinicalTrials.gov-linked program for FENNEC, including Pedmark® STS. Open each program for phase, modality, NCT IDs, and indication details.

Where does FENNEC company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.